Start-Up Quarterly Statistics, Q1 2011

01 May 2011

• By Deanna Kamienski

Biopharma and medical device start-ups brought in a total of $216 million in Q1 2011. Absent were any financings involving in vitro diagnostics companies. Only four acquisitions involving start-ups were completed - one in biopharma and three in the device industry. Cancer was the most popular therapeutic category among biopharma start-up alliance this quarter.

Biopharmaceutical, medical device and in vitro diagnostics start-up dealmaking from January through March 2011. Data from Elsevier's Strategic Transactions.

Biopharma and medical device start-ups brought in a total of $216 million in the first quarter of 2011. There were...